Bayer shares slump after court tells firm to pay $2.25 billion over Monsanto weedkiller lawsuit

A Philadelphia jury ordered Bayer to pay $2.25 billion to John McKivision, who claims exposure to Roundup caused him to develop cancer

Previous post American Healthcare REIT, Fortegra and Fractyle Health set IPO price ranges as thaw continues
Next post REV to wind down transit-bus manufacturer ENC